Subscribe for the VF E-News HERE
We’re a team of healthcare writers and professionals who are committed to helping people with rheumatoid arthritis live full, happy lives despite their diagnosis. 121 S. Orange Ave, Orlando, Florida more »
Sites throughout the U.S. and Canada are seeking patients with newly diagnosed or relapsed anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This clinical trial is designed to determine whether a new non-steroidal more »
The Vasculitis Clinical Research Consortium (VCRC) investigators provided the answers to the questions below. If you have a question you would like answered, please contact the Vasculitis Foundation. Click here to access the FAQs.
The RITAZAREM Trial is an international, open label, randomized controlled trial comparing rituximab with azathioprine as maintenance therapy in relapsing ANCA-associated vasculitis. Rituximab is now established as an effective drug more »